InsightfulValue
← Home

Royalty Pharma
Royalty Pharma

Pharma / Pharmaceutical royalties and drug financing


πŸ”§ Tools

βœ… Due Diligence
πŸ“ Financial Growth

Pay attention and research significant changes from year to year values. [ ! ]

Revenue
Growth, %
Net Income
Growth, %
Operating Cash Flow
Growth, %
Free Cash Flow
Growth, %
EPS
Growth, %
EPS Diluted
Growth, %
Operating Income
Growth, %
EBIT
Growth, %
Gross Profit
Growth, %
Ten Y Revenue Growth
Per Share, %
Ten Y Net Income Growth
Per Share, %
Ten Y Operating CF Growth
Per Share, %
Ten Y Shareholders Equity Growth
Per Share, %
Five Y Revenue Growth
Per Share, %
Five Y Net Income Growth
Per Share, %
Five Y Operating CF Growth
Per Share, %
Five Y Shareholders Equity Growth
Per Share, %
Three Y Revenue Growth
Per Share, %
Three Y Net Income Growth
Per Share, %
Three Y Operating CF Growth
Per Share, %
Three Y Shareholders Equity Growth
Per Share, %
Book Value Per Share Growth, %Asset Growth, %Debt Growth, %Dividends per Share
Growth, %
Ten Y Dividend Per Share Growth
Per Share, %
Five Y Dividend Per Share Growth
Per Share, %
Three Y Dividend Per Share Growth
Per Share, %
Weighted Average Shares
Growth, %
Weighted Average Shares Diluted
Growth, %
Receivables Growth, %Inventory Growth, %R&D Expense Growth, %SGA Expenses Growth, %
2025-125.06 -10.24 -10.08 -10.08 20.7224.1320.664.855.06102.2886.36094.640.7 -28.94 9.9720.797.791725.2517.7616.69 -3 7.6717.583.750 -14.55 15.07 -3.16 -5.78 3178.31022500142.31
2024-12 -3.86 -24.3 -7.32 -7.32 -43.4 -42.68 -13.38 -17.53 -3.86 86.45101.080102.16 -0.91 -70.95 31.89 -9.64 -8.04 28.9127.6411.842.9311.2324.075.440 -59.55 22.77 -0.36 -1.47 20.310 -96.15 -5.23
2023-12****************************************************************************************************************************************
2022-12****************************************************************************************************************************************
2021-12****************************************************************************************************************************************
2020-12****************************************************************************************************************************************
2019-12****************************************************************************************************************************************
2018-12****************************************************************************************************************************************
2017-12****************************************************************************************************************************************
Royalty Pharma

πŸ“Š Explore more financial growth data for Royalty Pharma!

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal